Drug Trial Radar · NCT00465517
A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures
Last checked: Nov 19, 2026Latest source record: Mar 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
147
Actual
Start
Feb 2007
Primary completion
Oct 2008
Study completion Nov 2008
Sponsor
- Lead sponsor
- Marinus PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Apr 25, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 69 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3 antiepileptic medications (AEDs). The study will also evaluate the effectiveness of ganaxolone in females with catamenial epilepsy. Catamenial epilepsy refers to a relationship between seizure frequency and a woman's menstrual cycle, where the number of seizures increases around the time of a woman's menstrual cycle.
Conditions
- Partial Epilepsy
- Catamenial Epilepsy
Interventions
GanaxoloneDrug
Oral suspension 200-500 mg 3x/day
PlaceboOther
non-active placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Weekly Log-transformed Seizure Frequency During Weeks 1 Through 10Time frame: Week 1 through Week 10
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
Barrow Neurological Institute
Phoenix, Arizona
Arkansas Epilepsy Program
Little Rock, Arkansas
University of Southern California Adult Comprehensive Epilepsy Center
Los Angeles, California
University of California-Davis
Sacramento, California
Anchutz Outpatient Pavillion Neurosciences Clinic/ University of Colorado Hospital
Aurora, Colorado
Yale University School of Medicine
New Haven, Connecticut
University of Florida McKnight Brain Institute
Gainesville, Florida
Intercoastal Medicine
Sarasota, Florida
Emory HealthCare
Atlanta, Georgia
Southern Illinois University Medical Center
Springfield, Illinois
University of Iowa Hospitals and Clinics
Iowa City, Iowa
University of Kentucky, Dept. of Neurology
Lexington, Kentucky
Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland
2799 West Grand blvd. CFP 071
Detroit, Michigan
Minnesota Epilepsy Group, PA
Saint Paul, Minnesota
Comprehensive Epilepsy Care Center for Children and Adults
Chesterfield, Missouri
Overlook Hospital and Hackensack Medical Center
Hackensack, New Jersey
Neurosciences Institute at Albany Medical Center
Albany, New York
SUNY Upstate Medical University
Syracuse, New York
Ohio State University Medical Center
Columbus, Ohio
Riddle Health Care Center for Neuroscience
Media, Pennsylvania
Drexel University / Hahneman Hospital
Philadelphia, Pennsylvania
Thomas Jefferson University
Philadelphia, Pennsylvania
Vanderbilt University Medical Ctr
Nashville, Tennessee
Neurological Clinic of Texas, P.A.
Dallas, Texas
Virginia Commonwealth University
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.